Brin MF - Search Results

1

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.

Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT Chronic Migraine Study Group. Dodick DW, et al. Among authors: brin mf. Headache. 2010 Jun;50(6):921-36. doi: 10.1111/j.1526-4610.2010.01678.x. Epub 2010 May 7. Headache. 2010. PMID: 20487038 Clinical Trial.

2

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.

Brin MF, Lyons KE, Doucette J, Adler CH, Caviness JN, Comella CL, Dubinsky RM, Friedman JH, Manyam BV, Matsumoto JY, Pullman SL, Rajput AH, Sethi KD, Tanner C, Koller WC. Brin MF, et al. Neurology. 2001 Jun 12;56(11):1523-8. doi: 10.1212/wnl.56.11.1523. Neurology. 2001. PMID: 11402109 Clinical Trial.

3

Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.

Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD; BOTOX CDH Study Group. Dodick DW, et al. Among authors: brin mf. Headache. 2005 Apr;45(4):315-24. doi: 10.1111/j.1526-4610.2005.05068.x. Headache. 2005. PMID: 15836567 Clinical Trial.

4

Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.

Turkel CC, Bowen B, Liu J, Brin MF. Turkel CC, et al. Among authors: brin mf. Arch Phys Med Rehabil. 2006 Jun;87(6):786-92. doi: 10.1016/j.apmr.2006.02.015. Arch Phys Med Rehabil. 2006. PMID: 16731213

5

Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.

Yablon SA, Brashear A, Gordon MF, Elovic EP, Turkel CC, Daggett S, Liu J, Brin MF. Yablon SA, et al. Among authors: brin mf. Clin Ther. 2007 Apr;29(4):683-90. doi: 10.1016/j.clinthera.2007.04.015. Clin Ther. 2007. PMID: 17617291

6

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group. Aurora SK, et al. Among authors: brin mf. Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17. Cephalalgia. 2010. PMID: 20647170 Clinical Trial.

7

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF; PREEMPT 2 Chronic Migraine Study Group. Diener HC, et al. Among authors: brin mf. Cephalalgia. 2010 Jul;30(7):804-14. doi: 10.1177/0333102410364677. Epub 2010 Mar 17. Cephalalgia. 2010. PMID: 20647171 Clinical Trial.

8

Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications.

Naumann M, Carruthers A, Carruthers J, Aurora SK, Zafonte R, Abu-Shakra S, Boodhoo T, Miller-Messana MA, Demos G, James L, Beddingfield F, VanDenburgh A, Chapman MA, Brin MF. Naumann M, et al. Among authors: brin mf. Mov Disord. 2010 Oct 15;25(13):2211-8. doi: 10.1002/mds.23254. Mov Disord. 2010. PMID: 20737546

9

OnabotulinumtoxinA for treatment of chronic migraine: a response.

Dodick DW, Turkel CC, Degryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF. Dodick DW, et al. Among authors: brin mf. Headache. 2011 Jun;51(6):1005-8. doi: 10.1111/j.1526-4610.2011.01925.x. Epub 2011 May 17. Headache. 2011. PMID: 21592099 No abstract available.

10

Efficacy, tolerability, and immunogenicity of onabotulinumtoxina in a randomized, double-blind, placebo-controlled trial for cervical dystonia.

Charles D, Brashear A, Hauser RA, Li HI, Boo LM, Brin MF; CD 140 Study Group. Charles D, et al. Among authors: brin mf. Clin Neuropharmacol. 2012 Sep-Oct;35(5):208-14. doi: 10.1097/WNF.0b013e31826538c7. Clin Neuropharmacol. 2012. PMID: 22948497 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters